540 related articles for article (PubMed ID: 25216827)
1. Review of policy and status of implementation of collaborative HIV-TB activities in 23 high-burden countries.
Gupta S; Granich R; Date A; Lepere P; Hersh B; Gouws E; Samb B
Int J Tuberc Lung Dis; 2014 Oct; 18(10):1149-58. PubMed ID: 25216827
[TBL] [Abstract][Full Text] [Related]
2. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.
Semu M; Fenta TG; Medhin G; Assefa D
BMC Infect Dis; 2017 Jan; 17(1):5. PubMed ID: 28049455
[TBL] [Abstract][Full Text] [Related]
4. Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues.
Aït-Khaled N; Alarcon E; Bissell K; Boillot F; Caminero JA; Chiang CY; Clevenbergh P; Dlodlo R; Enarson DA; Enarson P; Ferroussier O; Fujiwara PI; Harries AD; Heldal E; Hinderaker SG; Kim SJ; Lienhardt C; Rieder HL; Rusen ID; Trébucq A; Van Deun A; Wilson N
Int J Tuberc Lung Dis; 2009 Aug; 13(8):927-35. PubMed ID: 19723371
[TBL] [Abstract][Full Text] [Related]
5. Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control ("Three I's") and HIV-Tuberculosis Service Integration in Lower Income Countries.
Charles MK; Lindegren ML; Wester CW; Blevins M; Sterling TR; Dung NT; Dusingize JC; Avit-Edi D; Durier N; Castelnuovo B; Nakigozi G; Cortes CP; Ballif M; Fenner L;
PLoS One; 2016; 11(4):e0153243. PubMed ID: 27073928
[TBL] [Abstract][Full Text] [Related]
6. New vaccines for the prevention of tuberculosis in human immunodeficiency virus infection.
von Reyn CF; Bakari M; Arbeit RD; Lahey T; Ramadhani A; Egwaga S
Int J Tuberc Lung Dis; 2012 Jun; 16(6):718-23. PubMed ID: 22507085
[TBL] [Abstract][Full Text] [Related]
7. Use of isoniazid preventive therapy for tuberculosis prophylaxis among people living with HIV/AIDS: a review of the literature.
Briggs MA; Emerson C; Modi S; Taylor NK; Date A
J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3(Suppl 3):S297-305. PubMed ID: 25768869
[TBL] [Abstract][Full Text] [Related]
8. Challenges and opportunities to prevent tuberculosis in people living with HIV in low-income countries.
Harries AD; Schwoebel V; Monedero-Recuero I; Aung TK; Chadha S; Chiang CY; Conradie F; Dongo JP; Heldal E; Jensen P; Nyengele JPK; Koura KG; Kumar AMV; Lin Y; Mlilo N; Nakanwagi-Mukwaya A; Ncube RT; Nyinoburyo R; Oo NL; Patel LN; Piubello A; Rusen ID; Sanda T; Satyanarayana S; Syed I; Thu AS; Tonsing J; Trébucq A; Zamora V; Zishiri C; Hinderaker SG; Aït-Khaled N; Roggi A; Caminero Luna J; Graham SM; Dlodlo RA; Fujiwara PI
Int J Tuberc Lung Dis; 2019 Feb; 23(2):241-251. PubMed ID: 30808459
[TBL] [Abstract][Full Text] [Related]
9. Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania.
Kabali C; von Reyn CF; Brooks DR; Waddell R; Mtei L; Bakari M; Matee M; Pallangyo K; Arbeit RD; Horsburgh CR
Int J Tuberc Lung Dis; 2011 Nov; 15(11):1515-21, i. PubMed ID: 22008766
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of the Three I's for HIV/TB and ART to prevent TB among people living with HIV.
Gupta S; Abimbola T; Date A; Suthar AB; Bennett R; Sangrujee N; Granich R
Int J Tuberc Lung Dis; 2014 Oct; 18(10):1159-65. PubMed ID: 25216828
[TBL] [Abstract][Full Text] [Related]
11. A clinical and epidemiologic update on the interaction between tuberculosis and human immunodeficiency virus infection in adults.
Habib AG
Ann Afr Med; 2009; 8(3):147-55. PubMed ID: 19884690
[TBL] [Abstract][Full Text] [Related]
12. Implementation of isoniazid preventive therapy in an HIV clinic in Cambodia: high rates of discontinuation when combined with antiretroviral therapy.
van Griensven J; Choun K; Chim B; Thai S; Lorent N; Lynen L
Trop Med Int Health; 2015 Dec; 20(12):1823-31. PubMed ID: 26426387
[TBL] [Abstract][Full Text] [Related]
13. A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda.
Sensalire S; Karungi Karamagi Nkolo E; Nabwire J; Lawino A; Kiragga D; Muhire M; Kadama H; Katureebe C; Namuwenge P; Musinguzi J; Calnan J; Seyoum D
AIDS Res Ther; 2020 May; 17(1):28. PubMed ID: 32460788
[TBL] [Abstract][Full Text] [Related]
14. CD4+ cell count stratification to guide tuberculosis preventive therapy for people living with HIV.
Chaisson LH; Saraceni V; Cohn S; Seabrook D; Cavalcante SC; Chaisson RE; Golub JE; Durovni B
AIDS; 2020 Jan; 34(1):139-147. PubMed ID: 31634189
[TBL] [Abstract][Full Text] [Related]
15. Prevention of tuberculosis in people living with HIV.
Granich R; Akolo C; Gunneberg C; Getahun H; Williams P; Williams B
Clin Infect Dis; 2010 May; 50 Suppl 3():S215-22. PubMed ID: 20397951
[TBL] [Abstract][Full Text] [Related]
16. Global guidelines for treatment of tuberculosis among persons living with HIV: unresolved issues.
Kumar A; Kumar AM; Gupta D; Kanchar A; Mohammed S; Srinath S; Tripathy S; Rajasekaran S; Chan PL; Swaminathan S; Dewan PK
Int J Tuberc Lung Dis; 2012 May; 16(5):573-8. PubMed ID: 22507931
[TBL] [Abstract][Full Text] [Related]
17. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
18. Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV.
Date AA; Vitoria M; Granich R; Banda M; Fox MY; Gilks C
Bull World Health Organ; 2010 Apr; 88(4):253-9. PubMed ID: 20431788
[TBL] [Abstract][Full Text] [Related]
19. Community-based multi-disease prevention campaigns for controlling human immunodeficiency virus-associated tuberculosis.
Suthar AB; Klinkenberg E; Ramsay A; Garg N; Bennett R; Towle M; Sitienei J; Smyth C; Daniels C; Baggaley R; Gunneberg C; Williams B; Getahun H; van Gorkom J; Granich RM
Int J Tuberc Lung Dis; 2012 Apr; 16(4):430-6. PubMed ID: 22640510
[TBL] [Abstract][Full Text] [Related]
20. The cost of intensified case finding and isoniazid preventive therapy for HIV-infected patients in Battambang, Cambodia.
Sutton BS; Arias MS; Chheng P; Eang MT; Kimerling ME
Int J Tuberc Lung Dis; 2009 Jun; 13(6):713-8. PubMed ID: 19460246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
